Research programme: liver disorders stem cell therapy - Microbot Medical
Alternative Names: hLEC; Human liver engrafting cells - Microbot Medical; Liver Program - Microbot MedicalLatest Information Update: 04 Nov 2017
At a glance
- Originator StemCells
- Developer Microbot Medical
- Class Stem cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Liver-disorders in USA (Parenteral)
- 28 Nov 2016 StemCells has been acquired and merged into Microbot Medical
- 19 Jul 2012 Preclinical development is ongoing in USA